Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Laser Photonics Announces Strategic Milestone on Advanced Laser Shield Anti Drone System (click to learn more) This emerging Bitcoin infrastructure company is building a vertically integrated model (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Shanghai Pharmaceuticals Holdings Company Ltd (PK) SHPMF

Alternate Symbol(s):  SHPMY

Healthcare Medical Distribution
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology... see more

Recent & Breaking News (PINL:SHPMF)

    ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies

    PR Newswire August 6, 2020

    Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval

    PR Newswire September 30, 2019

    Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition

    PR Newswire April 15, 2019

    Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound

    PR Newswire Europe Non Regulatory May 22, 2018

    Cardinal Health Signs Definitive Agreement to Sell its China Business to Shanghai Pharma

    PR Newswire November 14, 2017

    Shanghai Pharmaceuticals Achieves Rapid Business Growth for 3Q2014; Realized Double-Digit Growth of Revenue and Profit

    PR Newswire October 29, 2014

    Shanghai Pharmaceuticals Achieves Double-Digit Growth of Revenue and Profit for 1H2014

    PR Newswire August 29, 2014

    Shanghai Pharmaceuticals Records a Growth of 8.6% in Operating Revenue in 1Q2014

    PR Newswire April 28, 2014

      Podcasts